Evidence map›Paper›PMID 33463071›Full record

ArticleClinical and translational medicine2021

CD73 alleviates GSDMD-mediated microglia pyroptosis in spinal cord injury through PI3K/AKT/Foxo1 signaling.

Shun Xu, Jin Wang, Junjie Zhong, Minghao Shao, Jianyuan Jiang, Jian Song, Wei Zhu, Fan Zhang, Haocheng Xu, Guangyu Xu and 3 more

Open access · goldAbstract read
In one paragraph

Article in Clinical and translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 129 papers.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 235 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Notch2 Directs aTreg Cell Fate Toward Immunoregulation or Inflammatory Pyroptosis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  13. Article
  14. De novo discovery of bicyclic cysteine-rich peptides targeting gasdermin D.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Shun XuDepartment of Orthopedics, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Jin WangDepartment of Orthopedics, Huashan Hospital, Fudan University, Shanghai, China.
Junjie ZhongDepartment of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
Minghao ShaoDepartment of Orthopedics, Huashan Hospital, Fudan University, Shanghai, China.
Jianyuan JiangDepartment of Orthopedics, Huashan Hospital, Fudan University, Shanghai, China.
Jian SongDepartment of Orthopedics, Huashan Hospital, Fudan University, Shanghai, China.
Wei ZhuDepartment of Orthopedics, Huashan Hospital, Fudan University, Shanghai, China.
Fan ZhangDepartment of Orthopedics, Huashan Hospital, Fudan University, Shanghai, China.
Haocheng XuDepartment of Orthopedics, Huashan Hospital, Fudan University, Shanghai, China.
Guangyu XuDepartment of Orthopedics, Huashan Hospital, Fudan University, Shanghai, China.
Yuxuan ZhangDepartment of Orthopedics, Huashan Hospital, Fudan University, Shanghai, China.
Xiaosheng MaDepartment of Orthopedics, Huashan Hospital, Fudan University, Shanghai, China.
Feizhou LyuDepartment of Orthopedics, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.ORCID 0000-0001-8887-5554
Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeuroinflammation-induced secondary injury is an important cause of sustained progression of spinal cord injury. Inflammatory programmed cell death pyroptosis executed by the pore-forming protein gasdermin D (GSDMD) is an essential step of neuroinflammation. However, it is unclear whether CD73, a widely accepted immunosuppressive molecule, can inhibit pyroptosis via mediating GSDMD.

methodsC57BL/6J CD73 deficient mice and wild-type mice, Lipopolysaccharide (LPS)-induced primary microglia and BV2 cells were respectively used to illustrate the effect of CD73 on microglia pyroptosis in vivo and in vitro. A combination of molecular and histological methods was performed to assess pyroptosis and explore the mechanism both in vivo and in vitro.

resultsWe have shown molecular evidence for CD73 suppresses the activation of NLRP3 inflammasome complexes to reduce the maturation of GSDMD, leading to decreased pyroptosis in microglia. Further analysis reveals that adenosine-A

conclusionOur data reveal a novel function of CD73 on microglia pyroptosis, suggesting a unique therapeutic opportunity for mitigating the disease process in SCI.

Indexed as

5'-NucleotidaseAnimalsCells, CulturedDisease Models, AnimalForkhead Box Protein O1GasderminsIntracellular Signaling Peptides and ProteinsMiceMice, Inbred C57BLMicrogliaPhosphate-Binding ProteinsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktPyroptosisSignal TransductionSpinal Cord Injuries5'-NucleotidaseForkhead Box Protein O1Foxo1 protein, mouseGasderminsGsdmd protein, mouseIntracellular Signaling Peptides and ProteinsPhosphate-Binding ProteinsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-akt

Identifiers

PMID33463071
PMCPMC7774461
OpenAlexW3112774972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.